Literature DB >> 21431562

Improved prediction of MHC class I binders/non-binders peptides through artificial neural network using variable learning rate: SARS corona virus, a case study.

Sudhir Singh Soam1, Bharat Bhasker, Bhartendu Nath Mishra.   

Abstract

Fundamental step of an adaptive immune response to pathogen or vaccine is the binding of short peptides (also called epitopes) to major histocompatibility complex (MHC) molecules. The various prediction algorithms are being used to capture the MHC peptide binding preference, allowing the rapid scan of entire pathogen proteomes for peptide likely to bind MHC, saving the cost, effort, and time. However, the number of known binders/non-binders (BNB) to a specific MHC molecule is limited in many cases, which still poses a computational challenge for prediction. The training data should be adequate to predict BNB using any machine learning approach. In this study, variable learning rate has been demonstrated for training artificial neural network and predicting BNB for small datasets. The approach can be used for large datasets as well. The dataset for different MHC class I alleles for SARS Corona virus (Tor2 Replicase polyprotein 1ab) has been used for training and prediction of BNB. A total of 90 datasets (nine different MHC class I alleles with tenfold cross validation) have been retrieved from IEDB database for BNB. For fixed learning rate approach, the best value of AROC is 0.65, and in most of the cases it is 0.5, which shows the poor predictions. In case of variable learning rate, of the 90 datasets the value of AROC for 76 datasets is between 0.806 and 1.0 and for 7 datasets the value is between 0.7 and 0.8 and for rest of 7 datasets it is between 0.5 and 0.7, which indicates very good performance in most of the cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431562      PMCID: PMC7123181          DOI: 10.1007/978-1-4419-7046-6_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Reverse vaccinology, a genome-based approach to vaccine development.

Authors:  R Rappuoli
Journal:  Vaccine       Date:  2001-03-21       Impact factor: 3.641

Review 2.  Immuno-informatics: Mining genomes for vaccine components.

Authors:  Anne S De Groot; Hakima Sbai; Caitlin Saint Aubin; Julie McMurry; William Martin
Journal:  Immunol Cell Biol       Date:  2002-06       Impact factor: 5.126

Review 3.  SARS coronavirus: a new challenge for prevention and therapy.

Authors:  Kathryn V Holmes
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 4.  Genome-derived vaccines.

Authors:  Anne S De Groot; Rino Rappuoli
Journal:  Expert Rev Vaccines       Date:  2004-02       Impact factor: 5.217

5.  Peptide binding at class I major histocompatibility complex scored with linear functions and support vector machines.

Authors:  Henning Riedesel; Björn Kolbeck; Oliver Schmetzer; Ernst-Walter Knapp
Journal:  Genome Inform       Date:  2004

Review 6.  T cell vaccines for microbial infections.

Authors:  Harriet L Robinson; Rama Rao Amara
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 7.  Methods and protocols for prediction of immunogenic epitopes.

Authors:  Joo Chuan Tong; Tin Wee Tan; Shoba Ranganathan
Journal:  Brief Bioinform       Date:  2006-10-31       Impact factor: 11.622

8.  Prediction of MHC binding peptide using Gibbs motif sampler, weight matrix and artificial neural network.

Authors:  Satarudra Prakash Singh; Bhartendu Nath Mishra
Journal:  Bioinformation       Date:  2008-12-06

9.  Prediction of MHC class I binding peptides using probability distribution functions.

Authors:  Sudhir Singh Soam; Feroz Khan; Bharat Bhasker; Bhartendu Nath Mishra
Journal:  Bioinformation       Date:  2009-06-28

10.  Critical role of glycosylation in determining the length and structure of T cell epitopes.

Authors:  Tamás G Szabó; Robin Palotai; Péter Antal; Itay Tokatly; László Tóthfalusi; Ole Lund; György Nagy; András Falus; Edit I Buzás
Journal:  Immunome Res       Date:  2009-09-24
View more
  3 in total

1.  Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.

Authors:  Ernesto S Nakayasu; Tiago J P Sobreira; Rafael Torres; Luciane Ganiko; Paulo S L Oliveira; Alexandre F Marques; Igor C Almeida
Journal:  J Proteome Res       Date:  2011-12-08       Impact factor: 4.466

2.  What Can COVID-19 Teach Us about Using AI in Pandemics?

Authors:  Krzysztof Laudanski; Gregory Shea; Matthew DiMeglio; Mariana Rastrepo; Cassie Solomon
Journal:  Healthcare (Basel)       Date:  2020-12-01

Review 3.  Utility of Artificial Intelligence Amidst the COVID 19 Pandemic: A Review.

Authors:  Agam Bansal; Rana Prathap Padappayil; Chandan Garg; Anjali Singal; Mohak Gupta; Allan Klein
Journal:  J Med Syst       Date:  2020-08-01       Impact factor: 4.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.